Clinical trials
Hepatic Encephalopathy trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2006 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Catania | 2 |
| A.O. Ospedale Papa Giovanni XXIII | 1 |
| Axcella Health, Inc | 1 |
| Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 1 |
| Bausch Health Americas, Inc. | 1 |
| Fadoi Foundation, Italy | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Ocera Therapeutics, Inc. | 1 |
| Prof. Valérie Mc Lin | 1 |
| University of Bari | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatic Encephalopathy | 12 |
| Fibrosis | 2 |
| Hyperammonemia | 2 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Clostridium Infections | 1 |
| Congenital Portosystemic Shunt | 1 |
| Dysbiosis | 1 |
| End Stage Liver Disease | 1 |
| Gastrointestinal Diseases | 1 |
| Hepatopulmonary Syndrome | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.